missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Research and Clinical Diagnostic Tests and Controls
  4. Flu and Virus Testing
  5. Multiplex COVID Testing Kits
  6. 30280603

MP Biomedicals Rapid SARS-CoV-2/Influenza A+B Antigen Duo Test Card

Product Code. 30280603 Shop All MP Biomedicals Products
Change view
Click to view available options
:
SARS-CoV-2 and Ifnluence Duo
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code.
30280603 SARS-CoV-2 and Ifnluence Duo
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 30280603 Supplier MP Biomedicals Supplier No. 07AG6020FL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

SARS-CoV-2 Ag+Flu A/Flu B Rapid Test is a one-step in vitro test based on immunochromatography.

  • Rapid SARS-CoV-2/Influenza A+B Antigen Duo Test Card is an immunochromatographic lateral flow device that employs the principle of double antibody sandwich method.
  • Anti-SARS-CoV-2, anti-influenza A and anti-influenza B antibodies are immobilized on the nitrocellulose membrane respectively, as three individual test lines (CoV line, Flu A line and Flu B line) in the test window of the test device.
  • When the specimen is added, it migrates by capillary diffusion through the strip to re-hydrate the gold conjugate complexes.
  • If present at or above the limit of detection, viral antigens will react with the gold conjugate complexes to form particles, which will continue to migrate along the strip until the Test Zone (T) where they are captured by the immobilized anti-SARS-CoV-2 or anti-influenza A or anti-influenza B antibodies to form a visible red line, which indicates positive test results.
  • Absence of this colored band in the test window indicates a negative test result.
  • The gold conjugate complexes will continue to migrate alone until being captured by immobilized antibody in the Control Zone (C) to form a red line, which indicates the validity of the test.
  • CE marked
  • For professional use only
  • Accurate Result within 15 to 20 minutes
  • One-step procedure
  • No equipment needed
  • No cross-reaction
  • High sensitivity, specificity, and accuracy
  • This test is only to be used by professional medical staff, not for home testing. It cannot be used alone as the basis for the diagnosis and exclusion of cases.

Specifications

CE Marker Self-declared
Clia Complexity Not Applicable
Detectable Analytes SARS-CoV-2, Influenza A and Influenza B Nucleoprotein Antigens
Detection Method Immunochromatographic lateral flow
DoA Calibrators No
Format Test card
Sample Type Human nasal swabs, Human nasopharyngeal swabs, Human oropharyngeal swabs
Sensitivity SARS-CoV-2: 1.3 x 102 TCID{50}/mL, Influenza A: 1.78 x 102 TCID{50}/mL, Influenza B: 1.17 x 103 TCID{50}/mL
Type Rapid Test
Disposable Single-use
For Use With (Application) Rapid and qualitative determination of SARS-CoV-2, Influenza type A and type B viral antigen in nasal swabs, nasopharyngeal swabs or oropharyngeal swabs
Specificity SARS-CoV-2: 99.16% (95% CI: 98.49% ~ 99.83%) Influenza A: 98.69% (95% CI: 97.42% ~ 99.97%) Influenza B: 99.37% (95% CI: 98.50% ~ 100%)
Form Ready-to-Use (RTU)
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.